The Wall Street Journal reported that Zoetis Inc., a former subsidiary of Pfizer Inc. (NYSE:PFE), raised approximately $2.2 billion in its initial public offering (IPO) — that makes it the largest IPO since Facebook Inc.’s (NASDAQ:FB) in May 2012.
The Wall Street Journal reported that Zoetis Inc., a former subsidiary of Pfizer Inc. (NYSE:PFE), raised approximately $2.2 billion in its initial public offering (IPO) — that makes it the largest IPO since Facebook Inc.’s (NASDAQ:FB) in May 2012.
As quoted in the market news:
The $26 price was more than the range of $22 to $25 initially outlined in documents filed with the Securities and Exchange Commission. Zoetis will command a market value of around $13 billion based on the offer price.
Zoetis, of Madison, N.J., is the largest animal-medicine company in the world by revenue. It makes vaccines and drugs for livestock such as cattle and swine, as well as for pets.
The Conversation (0)
Outlook Reports world
Featured Life Science Investing Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES